Arcturus Therapeutics Holdings Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -81.2% | -2.1% | -12.4% | +294.4% | -81.8% | +0.8% | +43.5% | +121.4% | -42.6% | +133.4% | -67.3% | -10.5% | -10.8% | -12.2% | +0.5% | -4.1% | -5.0% | -5.9% | +21.8% | +137.8% | -9.5% | +416.6% | -50.7% | +1,099.0% | -49.9% | -86.9% | +312.4% | -42.2% | +30.0% | +41.0% | -15.6% | -45.9% | +39.9% | -16.6% | -30.0% | -82.0% | -80.2% | +385.1% | – | |
| – | – | -81.0% | -5.8% | -5.5% | +22.2% | -9.5% | +7.2% | -6.1% | +22.1% | +51.1% | -0.8% | -3.0% | +70.1% | -34.0% | +0.3% | +122.8% | +26.5% | +123.6% | -8.7% | -0.6% | -32.3% | +46.1% | -14.9% | -1.3% | -28.4% | +91.9% | -92.8% | -78.6% | +1.9% | +10.9% | -0.4% | +0.0% | -9.0% | – | – | – | -79.6% | -3.5% | – | – | |
| – | – | -106.5% | – | – | – | -118.2% | – | – | – | -208.9% | – | -229.5% | – | – | -12.2% | +0.5% | -963.6% | – | – | – | – | – | – | – | – | -78.6% | -76.2% | +540.0% | -42.2% | +30.0% | +41.0% | -15.6% | -45.9% | +39.9% | -16.6% | -43.7% | -77.7% | -101.6% | – | – | |
| – | -30.5% | -53.7% | -30.0% | -26.6% | +972.3% | -65.3% | +7.2% | -6.1% | +22.1% | +51.1% | -0.8% | -3.0% | +70.1% | -34.0% | +0.3% | +122.8% | +37.2% | +106.1% | -8.7% | -0.6% | -28.1% | +37.6% | -14.9% | -1.3% | -28.4% | +91.9% | +1.7% | -3.0% | -28.3% | +46.3% | +9.5% | -33.3% | +11.9% | -20.3% | -15.2% | -21.3% | +5.2% | -14.5% | -16.3% | – | |
| – | +6.2% | -8.2% | +77.2% | -21.3% | +61.3% | +92.0% | +61.5% | -53.7% | -9.7% | +2.7% | -2.2% | +12.3% | +8.0% | +0.0% | +5.5% | +26.1% | +62.1% | +7.8% | +3.1% | +8.1% | -0.5% | -0.7% | +2.5% | +13.6% | -5.0% | +16.0% | -3.9% | +1.1% | -6.5% | +18.7% | -17.1% | +7.8% | -6.7% | -8.6% | -8.6% | +0.6% | +34.9% | -32.5% | +16.1% | – | |
| – | -23.1% | -40.4% | +5.2% | -24.4% | +354.4% | -31.2% | +37.8% | -37.6% | +6.5% | +31.0% | -1.2% | +1.9% | -83.6% | +576.0% | +2.1% | +88.2% | -53.0% | -10.9% | +3.1% | +8.1% | +17.0% | -15.6% | +2.5% | +13.6% | -5.0% | +16.0% | +351.6% | +0.9% | -30.9% | +45.4% | +6.5% | -26.2% | +9.8% | -15.0% | -21.8% | -16.1% | +13.4% | -13.5% | -4.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -87.9% | -475.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +340.1% | -79.3% | -73.6% | +93.9% | +760.9% | -99.4% | +3,385.7% | +23.0% | +22.7% | +10.3% | +1.5% | -0.5% | +17.1% | +5.8% | -23.2% | -2.6% | +0.5% | +185.9% | +30.0% | +0.1% | -0.4% | +1.4% | +1.4% | +5.1% | +3.3% | -5.9% | -100.0% | – | -80.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -57.1% | -202.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -33.3% | +20.0% | +0.0% | +125.0% | -285.2% | – | -100.0% | – | – | -128.0% | – | -39.8% | +737.5% | -141.2% | – | -330.5% | – | +961.5% | -105.3% | – | – | +1,239.0% | -24.4% | -228.1% | – | -92.0% | +460.2% | +54.8% | -70.7% | +40.5% | -140.8% | – | – | – | – | -417,150.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -56.7% | -203.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -12,668.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | -56.5% | -198.2% | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.